UCSF

Bero Comments on Corporate Funding and Academic Research

Lisa Bero, PhD, UCSF School of Pharmacy faculty member, looks at the potential benefits, risks, and ethical issues of different corporate/academic funding models. She also calls for a research agenda aimed at clarifying the effects of these relationships on research integrity, faculty attitudes, technology transfer, and research productivity. Her comments appear in the June 4, 2008 online version of the Journal of Epidemiology under the title "'Experimental institutional' models for corporate funding of academic research: Unknown effects on the research enterprise."

Full story

"Experimental" Institutional Models for Corporate Funding of Academic Research: Unknown Effects on the Research Enterprise


About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.